Gary Hammer
Gary Hammer
Professor
ghammer@umich.edu

Research Description

Research projects are aimed at elucidating the mechanisms by which growth factor signaling and transcriptional programs initiate adrenal-specific growth and differentiation with an emphasis on dysregulated growth of adrenocortical stem/progenitor cells in development and cancer.

Gary D. Hammer, M.D., Ph.D. serves as the Director of the Endocrine Oncology Program in the Comprehensive Cancer Center at UM where he holds the Millie Schembechler Professorship inAdrenal Cancer. Under his leadership, the Program was selected as one of five inaugural Destination Programs singled out for research and clinical excellence at UMHS. The Program is uniquely recognized as an international center of excellence for the treatment of adrenal cancer.

He is also the newly appointed Director of the University’s Center for Organogenesis that brings together groups and faculty – basic scientists and clinicians – focused on organ-specific problems spanning developmental disorders to cancer. Strong relationships with the stem cell community, tissue and biomedical engineering and clinical programs provide unparalleled opportunity for translational partnerships.

Research projects in his own laboratory are aimed at elucidating the mechanisms by which growth factor signaling and transcriptional programs initiate adrenal-specific growth and differentiation with an emphasis on dysregulated growth of adrenocortical stem/progenitor cells in development and cancer. This work has led to the development of new national and international therapeutic trials with biological-based therapies for adrenal diseases that target the molecular defects in stem cells while sparing normal tissue.

Education

Endocrinology and Metabolism Fellowship University of California-San Francisco
Internship and Residency Internal Medicine UCSF
Ph.D Tufts University Sackler School of Graduate Biomedical Sciences
M.D. Tufts University
B.A. Psychology magna cum laude University of Vermont